Brief: Gubra Announces Achievement Of Milestone From AbbVie
26/08/2026 06:11
BRIEF-Gubra Announces Achievement Of Milestone From AbbVie Aug 26 (Reuters) - Gubra A/S GUBRA.CO:
ANNOUNCES ACHIEVEMENT OF MILESTONE FROM ABBVIE FOLLOWING INITIATION OF PHASE 2 CLINICAL TRIAL OF ABBV-295, A LONG-ACTING AMYLIN ANALOG
INITIATION OF PHASE 2 TRIAL TRIGGERS A MILESTONE PAYMENT OF USD 50 MILLION TO GUBRA
Source text: ID:nMFN8Yw7Mq
Further company coverage: GUBRA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))